According to ChemoMetec's latest financial reports the company's current EPS (TTM) is $1.29. In 2022 the company made an earnings per share (EPS) of $1.29 an increase over its 2021 EPS that were of $0.81.
Year | EPS | Change |
---|---|---|
2022 | $1.29 | 58.2% |
2021 | $0.81 | 53.48% |
2020 | $0.53 | 29.38% |
2019 | $0.41 | 123.27% |
2018 | $0.18 | 148.32% |
2017 | $0.07385 | -26.3% |
2016 | $0.10 | 30.67% |
2015 | $0.07669 | 498.51% |
2014 | $0.01281 | 267.1% |
2013 | $0.003490 | -103.6% |
2012 | -$0.09706 | -5099.34% |
2011 | $0.001941 | -105.63% |
2010 | -$0.03448 | -170.35% |
2009 | $0.04901 | -70.99% |
2008 | $0.17 | 1311.59% |
2007 | $0.01197 | -99.97% |
2006 | $43.67 | -451.18% |
2005 | -$12.44 | -89.59% |
2004 | -$119.45 |